Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12253
Abstract: Atomoxetine (ATX) is a non‐central stimulant and a standard treatment for adult attention‐deficit/hyperactivity disorder (ADHD). The long‐term efficacy of Atomoxetine is about 40% at 6 months. The variability in efficacy between individuals is thought to be… read more here.
Keywords: hyperactivity disorder; attention deficit; efficacy; adult attention ... See more keywords